Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, signaling a new version of the page. This change reflects an update to the page's metadata rather than the study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6 to reflect a new deployment of the FIREFISH study page.SummaryDifference0.0%

- Check26 days agoChange DetectedA 2016 NIH grant/contract reference was added to the study record, linking a U.S. NIH funding source to BP39056 (EudraCT 2016-000778-40) and providing funding context for the FIREFISH study.SummaryDifference0.0%

- Check40 days agoChange DetectedPublication citation for the FIREFISH study was updated from online-ahead-of-print to the final published Lancet Child Adolesc Health article (Sept 2026) with full authorship and DOI. This aligns the study record with the finalized publication details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This indicates a small update to the site's documentation/versioning.SummaryDifference0.0%

- Check76 days agoChange DetectedA new FIREFISH publication citation was added and the page revision updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.